University Hospital Schleswig-holstein

This study is observing how well an existing eczema medication called tralokinumab works for adults whose moderate-to-severe eczema specifically affects their genital area. About 30 participants will receive the medication as part of their normal care and be monitored for one yea…

This study is testing if starting treatment with a newer injectable biologic drug (mirikizumab) right away leads to better long-term disease control for people newly diagnosed with moderate-to-severe ulcerative colitis. It compares this 'top-down' approach to the current standard…

This study monitors women who had preeclampsia, HELLP syndrome, or kidney problems during pregnancy to understand their long-term heart and kidney health risks. Researchers will measure blood vessel stiffness and collect health data without changing participants' standard medical…

This study aims to find early warning signs of Parkinson's disease in people who don't yet have symptoms. Researchers will screen 2,000 adults aged 50-99 who are at higher risk and follow them for five years to see who develops the disease. The goal is to understand how Parkinson…

This study is trying to understand why many people with Parkinson's disease crave sugary foods. Researchers will give 50 participants a sugary drink or a placebo drink on different days to see how it affects their blood sugar, insulin levels, and Parkinson's symptoms like movemen…